Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

M/s. Genix Pharma (Pvt) Ltd.

Private pharmaceutical manufacturer · Karachi · Pakistan

Pharmaceutical manufacturer founded in 2004 with a broad portfolio of prescription and OTC medicines and an export presence.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗ LinkedIn ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date4 Aug 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Genix Pharma (Private) Limited
Company type
Private pharmaceutical manufacturer
Address
44, 45-B, Korangi Creek Road, Karachi-75190, Pakistan · 75190
Phone
+92 21 111 10 10 11
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000351 Genix Pharma (Pvt) Ltd. · Sindh
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000351 298 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx300public portfolio records represented
REG231unique registrations represented
IDX297indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+1registry-only registrations
VER1registry-verified exact registrations
PKR297current validated price records
G97generic molecules in indexed catalogue
DF12dosage-form groups
TA14therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage99%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixM/s. Genix Pharma (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 25 Sep 2026Anti-infectives140 · 47%CNS & mental health43 · 14%Cardiovascular21 · 7%Gastrointestinal & hepatology19 · 6%Hematology & thrombosis15 · 5%Pain & musculoskeletal15 · 5%Endocrine & metabolic9 · 3%Other therapeutic areas35 · 12%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioM/s. Genix Pharma (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 25 Sep 2026297presentationsTablet156 · 53%Injection56 · 19%Suspension23 · 8%Capsule22 · 7%Infusion16 · 5%Solution12 · 4%Other forms12 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionM/s. Genix Pharma (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 25 Sep 2026258comparable productsBelow peer median47 · 18%Near peer median91 · 35%Above peer median120 · 47%Company median price position+4.8%Lowest-price equivalents32Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsM/s. Genix Pharma (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/m-s-genix-pharma-pvt-ltdGenerated 25 Sep 2026Neutro Pharma (Pvt.) Ltd.,50 shared52% overlapNabiqasim Industries (Pvt) Ltd.,49 shared51% overlapMacter International Limited46 shared47% overlapGenome Pharmaceuticals (Pvt.) Ltd.46 shared47% overlapGlobal Pharmaceuticals (Pvt.) Ltd.45 shared46% overlapPharmasol (Pvt) Ltd.44 shared45% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives140 products · 47%
CNS & mental health43 products · 14%
Cardiovascular21 products · 7%
Gastrointestinal & hepatology19 products · 6%
Hematology & thrombosis15 products · 5%
Pain & musculoskeletal15 products · 5%
Endocrine & metabolic9 products · 3%
Respiratory & allergy9 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antivirals33 products · 11%
Antiepileptics24 products · 8%
Antimalarials20 products · 7%
Third-generation cephalosporins18 products · 6%
Fluoroquinolone antibacterials13 products · 4%
Macrolide antibacterials13 products · 4%
Antipsychotics12 products · 4%
Analgesics / NSAIDs11 products · 4%
Formulation footprint

Dosage forms

Tablet156 products
Injection56 products
Suspension23 products
Capsule22 products
Infusion16 products
Solution12 products
Drops4 products
Inhalation4 products
Cream1 products
Sachet1 products
Suppository1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AclovirAciclovir 13presentations 200 mg, 200 mg/5 mL, 250 mg, 400 mg · Tablet, Syrup, Infusion #2 RecetamLevetiracetam 12presentations 100 mg/mL, 1000 mg, 250 mg, 500 mg · Solution, Tablet, Infusion #3 HadzoneCeftriaxone 11presentations 1 g, 2 g, 250 mg, 500 mg · Injection #4 ZyspanLinezolid 8presentations 100 mg/5 mL, 200 mg/100 mL, 400 mg, 400 mg/200 mL · Suspension, Solution, Tablet #5 EfecipCiprofloxacin 7presentations 125 mg/5 mL, 200 mg/100 mL, 250 mg, 250 mg/5 mL · Suspension, Infusion, Tablet #6 ExifinIbuprofen 7presentations 100 mg/5 mL, 200 mg/5 mL, 400 mg, 600 mg/100 mL · Suspension, Tablet, Infusion
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median4718% of comparable products
Near market median91within ±5% of median
Above market median12047% of comparable products
Lowest-price equivalents32ties included
Company median price position +4.8% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Vita-K 10 mg/mLPhytomenadione · Injection · 100's PKR 4.19/vial/unit-98.4% vs market median Amdivaz 250 mgMethyldopa · Tablet · 10X10's PKR 6.27/tablet-61.2% vs market median Monilstat 100,000 IU/mLNystatin · Oral drops · 30mL PKR 1.69/mL-43.4% vs market median Larith 500 mgClarithromycin · IV infusion · 1Vial PKR 170.61/vial/unit-41.2% vs market median Prozyl 500 mg/100 mLMetronidazole · IV infusion · 1Vial PKR 103.26/vial/unit-41.2% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 50shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 49shared generics Macter International Limited256 products · 93 generics 46shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 46shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 45shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 44shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers228Distinct registrations among indexed, published, presentation-validated products only
Verified price observations297
Products with a verified price297
Products with multiple price observations0
Source records with multiple versions288
Latest portfolio source check22 Sep 2026
Latest effective price date4 Aug 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

231 unique registration(s) · 297 indexed presentation(s) · 2 additional source-observed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Laxetil 120ml Lactulose 10 g Solution 120ml 120159 PKR 305.66 PKR 2.55/mL 6% above median
Laxetil 240ml Lactulose 10 g Solution 240ml 120159 PKR 578.29 PKR 2.41/mL 5% below median
Lets Letrozole 2.5 mg Tablet 10's 086610 PKR 4,698.25 PKR 469.83/tablet 17% above median
Leucoarte CA Calcium folinate (folinic acid) 15 mg/2 mL Injection 2ml x 1’s 094869 PKR 342.91 PKR 171.46/mL No comparator
Leucoarte CA Calcium folinate (folinic acid) 50 mg/5 mL Injection 5ml x 10’s 094870 PKR 8,753.07 PKR 175.06/mL No comparator
Leucoarte CA Calcium folinate (folinic acid) 30 mg/3 mL Injection 3ml 118335 PKR 342.16 PKR 114.05/mL No comparator
Lidol Lidocaine 20 mg/mL Injection 100's 083280 PKR 363.95 PKR 3.64/vial/unit No comparator
Lidol Lidocaine 1% Injection 5ml 094865 PKR 21.47 PKR 4.29/mL 115% above median
Lidol Lidocaine 2 % Injection 2ml x 100’s 094866 PKR 559.58 PKR 2.80/mL 26% above median
Lidol Lidocaine 1% Injection 3.5ml x 100’s 094867 PKR 840.58 PKR 2.40/mL 8% above median
Lonila Allopurinol 300 mg Tablet 2X10's 117889 PKR 93.22 PKR 4.66/tablet 21% below median
Lonila Allopurinol 100 mg Tablet 100's 117890 PKR 152.11 PKR 1.52/tablet 22% below median
Lonila Allopurinol 100 mg Tablet 50's 117890 PKR 79.90 PKR 1.60/tablet 18% below median
Lopran Loperamide HCl 2 mg Capsule 6 x 10's 083273 PKR 390.00 PKR 6.50/capsule 27% above median
Mep Omeprazole 20 mg Capsule 14's 061625 PKR 297.41 PKR 21.24/capsule 8% above median
Mep Omeprazole 40 mg Capsule 14's 061626 PKR 516.32 PKR 36.88/capsule 6% above median
Mep Omeprazole 10 mg Capsule 14's 061627 PKR 144.58 PKR 10.33/capsule 27% below median
Mep Omeprazole 40 mg Powder for injection/infusion 1 Vial 073689 PKR 619.58 PKR 619.58/vial/unit No comparator
Mep Omeprazole 40 mg Powder for injection 1 Vial 073689 PKR 619.58 PKR 619.58/vial/unit 9% above median
Migsum Sumatriptan 25 mg Tablet 12's 067269 PKR 933.59 PKR 77.80/tablet Near median
Migsum Sumatriptan 50 mg Tablet 12's 067270 PKR 1,356.11 PKR 113.01/tablet Near median
Migsum Sumatriptan 100 mg Tablet 10's 067271 PKR 1,944.97 PKR 194.50/tablet 31% below median
Mite Misoprostol 200 mcg Tablet 28's 061870 PKR 586.28 PKR 20.94/tablet Near median
Mite Misoprostol 200 mcg Tablet 10's 061870 PKR 209.38 PKR 20.94/tablet Near median
Mite Misoprostol 100 mcg Tablet 10's 061871 PKR 129.73 PKR 12.97/tablet Near median
Mite Misoprostol 25 mcg Tablet 15's 067432 PKR 72.60 PKR 4.84/tablet Near median
Mite Misoprostol 50 mcg Tablet 15's 067433 PKR 116.75 PKR 7.78/tablet No comparator
Monilstat Nystatin 100,000 IU/mL Oral drops 30mL 020181 PKR 50.60 PKR 1.69/mL 43% below median
Moptol Timolol 5 mg/mL Ophthalmic drops 5ml 073682 PKR 185.88 PKR 37.18/mL Near median
Natper Aprepitant 125 mg Capsule 2's 115860 PKR 5,470.37 PKR 2,735.19/capsule 17% above median
Natper Aprepitant 40 mg Capsule 2's 115861 PKR 2,097.34 PKR 1,048.67/capsule 17% above median
Natper Aprepitant 80 mg Capsule 2's 115862 PKR 3,502.77 PKR 1,751.39/capsule 17% above median
Netamy Natamycin 5% Suspension 15ml 114457 PKR 361.42 PKR 24.09/mL No comparator
Olver Meropenem 1 g Injection 1's 080604 PKR 4,324.40 PKR 4,324.40/vial/unit 10% above median
Olver Meropenem 500 mg Injection 1's 080605 PKR 2,240.36 PKR 2,240.36/vial/unit 8% above median
Ondonix Ondansetron 8 mg Tablet 12's 081451 PKR 2,118.39 PKR 176.53/tablet 6% above median
Ondonix Ondansetron 8 mg Tablet 10's 081451 PKR 1,765.33 PKR 176.53/tablet 6% above median
Ondonix Ondansetron 4 mg Tablet 10's 081545 PKR 1,059.19 PKR 105.92/tablet 14% above median
Ondonix Ondansetron 4 mg Tablet 1's 081545 PKR 105.92 PKR 105.92/tablet 14% above median
Ondonix Ondansetron 8 mg/4 mL Injection 4ml x 5's 098651 PKR 4,773.42 PKR 238.67/mL Near median
Ondonix Ondansetron 4 mg/2 mL Injection 2ml x 5's 107567 PKR 2,885.81 PKR 288.58/mL Near median
Ondonix Ondansetron 4 mg/5 mL Oral solution 50ml 123270 PKR 1,046.92 PKR 20.94/mL Near median
Orpak-ORS Oral rehydration salts (ORS) NaCl 2.60 g + KCl 1.50 g + trisodium citrate 2.90 g + glucose anhydrous 13.50 g / sachet Sachet 1's 020178 PKR 13.94 PKR 13.94/sachet 28% below median
Pire 4+ Rifampicin + Isoniazid + Pyrazinamide + Ethambutol 150 mg + 75 mg + 400 mg + 275 mg Tablet 8 x 10's 055531 PKR 1,972.09 PKR 24.65/tablet 35% below median
Pire-1 Ethambutol 400 mg Tablet 10 x 10's 091054 PKR 1,387.48 PKR 13.87/tablet 20% below median
Pire2 Rifampicin + Isoniazid 300 mg + 150 mg Tablet 10 x 10's 057870 PKR 2,635.63 PKR 26.36/tablet 62% above median
Pire3 Rifampicin + Isoniazid + Ethambutol 150 mg + 75 mg + 300 mg Tablet 10 x 8's 057871 PKR 1,341.49 PKR 16.77/tablet No comparator
Pire4 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol 120 mg + 60 mg + 225 mg + 300 mg Tablet 10 x 10's 057872 PKR 2,841.27 PKR 28.41/tablet No comparator
Propin SR Bupropion 75 mg Sustained-release tablet 1 x 10's 039040 PKR 222.28 PKR 22.23/tablet 14% above median
Propin SR Bupropion 150 mg Sustained-release tablet 1 x 10's 039041 PKR 333.42 PKR 33.34/tablet 16% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). M/s. Genix Pharma (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 25, 2026, from https://medinfobase.com/company/m-s-genix-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.